Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Gastric Electrical Stimulation Reduces Refractory Vomiting in a Randomized Crossover Trial.

Ducrotte P, Coffin B, Bonaz B, Fontaine S, Bruley Des Varannes S, Zerbib F, Caiazzo R, Grimaud JC, Mion F, Hadjadj S, Valensi PE, Vuitton L, Charpentier G, Ropert A, Altwegg R, Pouderoux P, Dorval E, Dapoigny M, Duboc H, Benhamou PY, Schmidt A, Donnadieu N, Gourcerol G, Guerci B; ENTERRA Research Group.

Gastroenterology. 2020 Feb;158(3):506-514.e2. doi: 10.1053/j.gastro.2019.10.018. Epub 2019 Oct 21.

PMID:
31647902
2.

Beneficial effects of Saccharomyces boulardii CNCM I-745 on clinical disorders associated with intestinal barrier disruption.

Terciolo C, Dapoigny M, Andre F.

Clin Exp Gastroenterol. 2019 Feb 11;12:67-82. doi: 10.2147/CEG.S181590. eCollection 2019. Review.

4.

Migraine prevalence in inflammatory bowel disease patients: A tertiary-care centre cross-sectional study.

Moisset X, Bommelaer G, Boube M, Ouchchane L, Goutte M, Dapoigny M, Dallel R, Guttmann A, Clavelou P, Buisson A.

Eur J Pain. 2017 Oct;21(9):1550-1560. doi: 10.1002/ejp.1056. Epub 2017 May 16.

PMID:
28508514
5.

Medical Therapies for Stricturing Crohn's Disease: Efficacy and Cross-Sectional Imaging Predictors of Therapeutic Failure.

Campos C, Perrey A, Lambert C, Pereira B, Goutte M, Dubois A, Goutorbe F, Dapoigny M, Bommelaer G, Hordonneau C, Buisson A.

Dig Dis Sci. 2017 Jun;62(6):1628-1636. doi: 10.1007/s10620-017-4572-4. Epub 2017 Apr 11.

PMID:
28401425
6.

Long-term outcome of endoscopic ultrasound-guided pelvic abscess drainage: a two-center series.

Poincloux L, Caillol F, Allimant C, Bories E, Pesenti C, Mulliez A, Faure F, Rouquette O, Dapoigny M, Abergel A, Giovannini M.

Endoscopy. 2017 May;49(5):484-490. doi: 10.1055/s-0042-122011. Epub 2017 Feb 14.

PMID:
28196390
7.

The human intestinal microbiota of constipated-predominant irritable bowel syndrome patients exhibits anti-inflammatory properties.

Gobert AP, Sagrestani G, Delmas E, Wilson KT, Verriere TG, Dapoigny M, Del'homme C, Bernalier-Donadille A.

Sci Rep. 2016 Dec 16;6:39399. doi: 10.1038/srep39399.

8.

Colonic overexpression of the T-type calcium channel Cav 3.2 in a mouse model of visceral hypersensitivity and in irritable bowel syndrome patients.

Scanzi J, Accarie A, Muller E, Pereira B, Aissouni Y, Goutte M, Joubert-Zakeyh J, Picard E, Boudieu L, Mallet C, Gelot A, Ardid D, Carvalho FA, Dapoigny M.

Neurogastroenterol Motil. 2016 Nov;28(11):1632-1640. doi: 10.1111/nmo.12860. Epub 2016 May 15.

PMID:
27196538
9.

Oral probiotic treatment of Lactobacillus rhamnosus Lcr35® prevents visceral hypersensitivity to a colonic inflammation and an acute psychological stress.

Darbaky Y, Evrard B, Patrier S, Falenta J, Garcin S, Tridon A, Dapoigny M, Silberberg C, Nivoliez A, Diop L.

J Appl Microbiol. 2017 Jan;122(1):188-200. doi: 10.1111/jam.13320. Epub 2016 Nov 21.

10.

Effects of scFOS on the composition of fecal microbiota and anxiety in patients with irritable bowel syndrome: a randomized, double blind, placebo controlled study.

Azpiroz F, Dubray C, Bernalier-Donadille A, Cardot JM, Accarino A, Serra J, Wagner A, Respondek F, Dapoigny M.

Neurogastroenterol Motil. 2017 Feb;29(2). doi: 10.1111/nmo.12911. Epub 2016 Jul 31.

PMID:
27477485
11.

Temporary placement of a covered duodenal stent can avoid riskier anterograde biliary drainage when ERCP for obstructive jaundice fails due to duodenal invasion.

Goutorbe F, Rouquette O, Mulliez A, Scanzi J, Goutte M, Dapoigny M, Abergel A, Poincloux L.

Surg Endosc. 2017 Feb;31(2):625-631. doi: 10.1007/s00464-016-5008-5. Epub 2016 Jun 20.

PMID:
27324333
12.

Endoscopy-based management decreases the risk of postoperative recurrences in Crohn's disease.

Boucher AL, Pereira B, Decousus S, Goutte M, Goutorbe F, Dubois A, Gagniere J, Borderon C, Joubert J, Pezet D, Dapoigny M, Déchelotte PJ, Bommelaer G, Buisson A.

World J Gastroenterol. 2016 Jun 7;22(21):5068-78. doi: 10.3748/wjg.v22.i21.5068.

13.

The Clinical Outcome in Patients Treated With a Newly Designed SEMS in Cervical Esophageal Strictures and Fistulas.

Poincloux L, Sautel C, Rouquette O, Pereira B, Goutte M, Bommelaer G, Dapoigny M, Abergel A.

J Clin Gastroenterol. 2016 May-Jun;50(5):379-87. doi: 10.1097/MCG.0000000000000501.

PMID:
26927492
14.

Usefulness of EUS-guided fine needle aspiration biopsy in the diagnosis of suspected or recurring lymphoproliferative disorders.

Poincloux L, André M, Darcha C, Goutte M, Dapoigny M, Bommelaer G, Abergel A, Tournilhac O.

Surg Oncol. 2016 Dec;25(4):459-465. doi: 10.1016/j.suronc.2015.08.007. Epub 2015 Sep 3.

PMID:
26362342
15.

Endoscopic ultrasound-guided biliary drainage after failed ERCP: cumulative experience of 101 procedures at a single center.

Poincloux L, Rouquette O, Buc E, Privat J, Pezet D, Dapoigny M, Bommelaer G, Abergel A.

Endoscopy. 2015 Sep;47(9):794-801. doi: 10.1055/s-0034-1391988. Epub 2015 May 11.

PMID:
25961443
16.

Blastocystis is associated with decrease of fecal microbiota protective bacteria: comparative analysis between patients with irritable bowel syndrome and control subjects.

Nourrisson C, Scanzi J, Pereira B, NkoudMongo C, Wawrzyniak I, Cian A, Viscogliosi E, Livrelli V, Delbac F, Dapoigny M, Poirier P.

PLoS One. 2014 Nov 3;9(11):e111868. doi: 10.1371/journal.pone.0111868. eCollection 2014.

17.

Pancreatic intubation facilitated by methylene blue injection decreases the risk for postpapillectomy acute pancreatitis.

Poincloux L, Scanzi J, Goutte M, Pereira B, Devaud H, Joubert J, Dapoigny M, Bommelaer G, Abergel A.

Eur J Gastroenterol Hepatol. 2014 Sep;26(9):990-5. doi: 10.1097/MEG.0000000000000146.

PMID:
25072383
18.

On-demand treatment with alverine citrate/simeticone compared with standard treatments for irritable bowel syndrome: results of a randomised pragmatic study.

Ducrotte P, Grimaud JC, Dapoigny M, Personnic S, O'Mahony V, Andro-Delestrain MC.

Int J Clin Pract. 2014 Feb;68(2):245-54. doi: 10.1111/ijcp.12333. Epub 2013 Oct 21.

19.

The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota.

Crouzet L, Gaultier E, Del'Homme C, Cartier C, Delmas E, Dapoigny M, Fioramonti J, Bernalier-Donadille A.

Neurogastroenterol Motil. 2013 Apr;25(4):e272-82. doi: 10.1111/nmo.12103. Epub 2013 Feb 25.

PMID:
23433203
20.

Review article: Associations between immune activation, intestinal permeability and the irritable bowel syndrome.

Matricon J, Meleine M, Gelot A, Piche T, Dapoigny M, Muller E, Ardid D.

Aliment Pharmacol Ther. 2012 Dec;36(11-12):1009-31. doi: 10.1111/apt.12080. Epub 2012 Oct 15. Review.

21.

Efficacy and safety profile of LCR35 complete freeze-dried culture in irritable bowel syndrome: a randomized, double-blind study.

Dapoigny M, Piche T, Ducrotte P, Lunaud B, Cardot JM, Bernalier-Donadille A.

World J Gastroenterol. 2012 May 7;18(17):2067-75. doi: 10.3748/wjg.v18.i17.2067.

22.

Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome.

Chassard C, Dapoigny M, Scott KP, Crouzet L, Del'homme C, Marquet P, Martin JC, Pickering G, Ardid D, Eschalier A, Dubray C, Flint HJ, Bernalier-Donadille A.

Aliment Pharmacol Ther. 2012 Apr;35(7):828-38. doi: 10.1111/j.1365-2036.2012.05007.x. Epub 2012 Feb 8.

23.

Large-balloon dilation of the sphincter of Oddi after sphincterotomy or infundibulotomy to extract large calculi or multiple common bile duct stones without using mechanical lithotripsy.

Poincloux L, Rouquette O, Privat J, Gorce D, Abergel A, Dapoigny M, Bommelaer G.

Scand J Gastroenterol. 2013 Feb;48(2):246-51. doi: 10.3109/00365521.2011.647064. Epub 2012 Jan 10.

PMID:
22229762
24.

A randomized controlled trial of endoscopist vs. anaesthetist-administered sedation for colonoscopy.

Poincloux L, Laquière A, Bazin JE, Monzy F, Artigues F, Bonny C, Abergel A, Dapoigny M, Bommelaer G.

Dig Liver Dis. 2011 Jul;43(7):553-8. doi: 10.1016/j.dld.2011.02.007. Epub 2011 Mar 29.

PMID:
21450542
25.

Nutrition economics - characterising the economic and health impact of nutrition.

Lenoir-Wijnkoop I, Dapoigny M, Dubois D, van Ganse E, Gutiérrez-Ibarluzea I, Hutton J, Jones P, Mittendorf T, Poley MJ, Salminen S, Nuijten MJ.

Br J Nutr. 2011 Jan;105(1):157-66. doi: 10.1017/S0007114510003041. Epub 2010 Aug 27.

26.

Impact of functional bowel symptoms on quality of life and fatigue in quiescent Crohn disease and irritable bowel syndrome.

Piche T, Ducrotté P, Sabate JM, Coffin B, Zerbib F, Dapoigny M, Hua M, Marine-Barjoan E, Dainese R, Hébuterne X.

Neurogastroenterol Motil. 2010 Jun;22(6):626-e174. doi: 10.1111/j.1365-2982.2010.01502.x. Epub 2010 Apr 19.

PMID:
20403099
27.

[Irritable bowel syndrome: epidemiology/economic burden].

Dapoigny M.

Gastroenterol Clin Biol. 2009 Feb;33 Suppl 1:S3-8. doi: 10.1016/S0399-8320(09)71519-2. French.

28.

[Clinical aspects and management of adult patients with acute gastroenteritis in primary care].

Bruley des Varannes S, Ducrotté P, Bueno L, Chassany O, Coffin B, Dapoigny M, Bonaz B, Savarieau B, Salin B.

Presse Med. 2009 Feb;38(2):177-84. doi: 10.1016/j.lpm.2008.11.011. Epub 2009 Jan 8. French.

PMID:
19135334
29.

Assessment of metabolic diversity within the intestinal microbiota from healthy humans using combined molecular and cultural approaches.

Chassard C, Scott KP, Marquet P, Martin JC, Del'homme C, Dapoigny M, Flint HJ, Bernalier-Donadille A.

FEMS Microbiol Ecol. 2008 Dec;66(3):496-504. doi: 10.1111/j.1574-6941.2008.00595.x. Epub 2008 Sep 22.

30.

Relationship between rectal sensitivity, symptoms intensity and quality of life in patients with irritable bowel syndrome.

Sabate JM, Veyrac M, Mion F, Siproudhis L, Ducrotte P, Zerbib F, Grimaud JC, Dapoigny M, Dyard F, Coffin B.

Aliment Pharmacol Ther. 2008 Aug 15;28(4):484-90. doi: 10.1111/j.1365-2036.2008.03759.x. Epub 2008 Jun 9.

31.

Irritable bowel syndrome in France: quality of life, medical management, and costs: the Encoli study.

Brun-Strang C, Dapoigny M, Lafuma A, Wainsten JP, Fagnani F.

Eur J Gastroenterol Hepatol. 2007 Dec;19(12):1097-103. Review.

PMID:
17998835
32.

[Recommendations for the clinical management and treatment of chronic constipation in adults].

Piche T, Dapoigny M, Bouteloup C, Chassagne P, Coffin B, Desfourneaux V, Fabiani P, Fatton B, Flammenbaum M, Jacquet A, Luneau F, Mion F, Moore F, Riou D, Senejoux A; French Gastroenterology Society.

Gastroenterol Clin Biol. 2007 Feb;31(2):125-35. Review. French. No abstract available.

33.

Recommandations pour la pratique clinique dans la prise en charge et le traitement de la constipation chronique de l'adulte: Recommendations for the clinical management and treatment of chronic constipation in adults.

Piche T, Dapoigny M, Bouteloup C, Chassagne P, Coffin B, Desfourneaux V, Fabiani P, Fatton B, Flammenbaum M, Jacquet A, Luneau F, Mion F, Moore F, Riou D, Senejoux A.

Gastroenterol Clin Biol. 2007 Feb;31(2):125-35. doi: 10.1016/S0399-8320(07)89342-0. French. No abstract available.

34.

Significance of patient-controlled sedation during colonoscopy. Results from a prospective randomized controlled study.

Crepeau T, Poincloux L, Bonny C, Lighetto S, Jaffeux P, Artigue F, Walleckx P, Bazin JE, Dapoigny M, Bommelaer G.

Gastroenterol Clin Biol. 2005 Nov;29(11):1090-6.

35.

Irritable bowel syndrome and the general practioners.

Dapoigny M.

Dig Liver Dis. 2005 Dec;37(12):907-8. Epub 2005 Sep 22. No abstract available.

PMID:
16182623
36.

Rectal instillation of butyrate provides a novel clinically relevant model of noninflammatory colonic hypersensitivity in rats.

Bourdu S, Dapoigny M, Chapuy E, Artigue F, Vasson MP, Dechelotte P, Bommelaer G, Eschalier A, Ardid D.

Gastroenterology. 2005 Jun;128(7):1996-2008.

PMID:
15940632
37.

Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.

Ducrotte P, Dapoigny M, Bonaz B, Siproudhis L.

Aliment Pharmacol Ther. 2005 Feb 15;21(4):435-44.

38.

[Constipation in the child and in the adult (with treatment)].

Dapoigny M, Raoux P.

Rev Prat. 2004 Oct 15;54(15):1699-704. French. No abstract available.

PMID:
15605585
39.

Irritable bowel syndrome in France: a common, debilitating and costly disorder.

Dapoigny M, Bellanger J, Bonaz B, Bruley des Varannes S, Bueno L, Coffin B, Ducrotté P, Flourié B, Lémann M, Lepicard A, Reigneau O.

Eur J Gastroenterol Hepatol. 2004 Oct;16(10):995-1001.

PMID:
15371923
40.

Quality of life and illness costs in irritable bowel syndrome.

Simrén M, Brazier J, Coremans G, Dapoigny M, Müller-Lissner SA, Pace F, Smout AJ, Stockbrügger RW, Vatn MH, Whorwell PJ.

Digestion. 2004;69(4):254-61. Epub 2004 Jul 14. Review.

PMID:
15256832
41.

Technologies in the evaluation of irritable bowel syndrome.

Smout AJ, Azpiroz F, Brummer RJ, Coremans G, Dapoigny M, Müller-Lissner SA, Pace F, Stockbrügger RM, Vatn M, Whorwell PJ.

Digestion. 2004;69(3):158-65. Epub 2004 Apr 28. Review.

PMID:
15118394
42.

Relationship between severity of symptoms and quality of life in 858 patients with irritable bowel syndrome.

Coffin B, Dapoigny M, Cloarec D, Comet D, Dyard F.

Gastroenterol Clin Biol. 2004 Jan;28(1):11-5.

43.

Role of alimentation in irritable bowel syndrome.

Dapoigny M, Stockbrügger RW, Azpiroz F, Collins S, Coremans G, Müller-Lissner S, Oberndorff A, Pace F, Smout A, Vatn M, Whorwell P.

Digestion. 2003;67(4):225-33. Review.

PMID:
12966230
44.

[Irritable bowel syndrome and healthcare consumption. An observational study in private gastroenterology].

Dapoigny M, Dyard F, Grimaud JC, Guyot P, van Ganse E.

Gastroenterol Clin Biol. 2003 Mar;27(3 Pt 1):265-71. French.

45.

Short-chain fatty acid enemas fail to decrease colonic hypersensitivity and inflammation in TNBS-induced colonic inflammation in rats.

Tarrerias AL, Millecamps M, Alloui A, Beaughard C, Kemeny JL, Bourdu S, Bommelaer G, Eschalier A, Dapoigny M, Ardid D.

Pain. 2002 Nov;100(1-2):91-7.

PMID:
12435462
46.

The rectum: a window to irritable bowel syndrome?

Coremans G, Azpiroz F, Collins S, Dapoigny M, Müller-Lissner SA, Pace F, Smout A, Stockbrügger RW, Whorwell PJ.

Digestion. 2002;65(4):238-49. Review.

PMID:
12239466
47.

Epidemiological aspects of irritable bowel syndrome in Europe and North America.

Müller-Lissner SA, Bollani S, Brummer RJ, Coremans G, Dapoigny M, Marshall JK, Muris JW, Oberndorff-Klein Wolthuis A, Pace F, Rodrigo L, Stockbrügger R, Vatn MH.

Digestion. 2001;64(3):200-4.

PMID:
11786669
48.

Nongastrointestinal disorders in the irritable bowel syndrome.

Azpiroz F, Dapoigny M, Pace F, Müller-Lissner S, Coremans G, Whorwell P, Stockbrügger RW, Smout A.

Digestion. 2000;62(1):66-72.

PMID:
10899728
49.

[Functional intestinal disorders. Diagnosis and treatment].

Dapoigny M.

Rev Prat. 1999 Sep 15;49(14):1559-64. French. No abstract available.

PMID:
10887603
50.

Potential pitfalls in the differential diagnosis of irritable bowel syndrome.

Smout A, Azpiroz F, Coremans G, Dapoigny M, Collins S, Müller-Lissner S, Pace F, Stockbrügger R, Vatn M, Whorwell P.

Digestion. 2000;61(4):247-56. Review. No abstract available.

PMID:
10878451

Supplemental Content

Loading ...
Support Center